Study exposes "slimming" drug companies

0
4



https://cdnarabic2.img.sputniknews.com/images/104374/76/1043747667.jpg

English – Sputnik News, Opinions & Radio

https://cdnarabic2.img.sputniknews.com/i/logo.png

https://arabic.sputniknews.com/mosaic/201912201043797856-%D8%AF%D8%B1%D8%A7%D8%B3%D8%A9-%D8%AA%D9%81%D8%B6%D8% AD-% D8% B4% D8% B1% D9% 83% D8% A7% D8% AA-% D8% A3% D8% AF% D9% 88% D9% 8A% D8% A9-% D8% A5% D9 % 86% D9% 82% D8% A7% D8% B5-% D8% A7% D9% 84% D9% 88% D8% B2% D9% 86-% D8% A7% D9% 84% D8% AA% D8 % AE% D8% B3% D9% 8A% D8% B3 /

Laboratory studies have long held about the reliability of slimming drugs and their effectiveness in losing weight in a short time. The German Commodity Test Authority decided to conduct accurate tests on the most popular slimming drugs on the German market.

The commission believes that there is no evidence to prove the sincerity of these promises. Rather, these drugs often lead to side effects. The commission reached this result after testing 13 types of slimming drugs, according to the German newspaper "dw".

The results showed that the drugs containing the drug "orlistat", "chitosan" and "liraglutide" have little effect, and have side effects such as nausea and diarrhea.

The body noted that drugs that are in the form of a powder dissolved in water, which replaces one or more meals per day, may have side effects as well, such as constipation.

And the authority warned against taking slimming medications containing "amphetamine", because of the risk of addiction and severe side effects such as heart palpitations, confusion, dizziness, and sleep difficulties.

The body recommends losing weight through a healthy diet and exercise, instead of slimming medications.



Source link
https://arabic.sputniknews.com/mosaic/201912201043797856-%D8%AF%D8%B1%D8%A7%D8%B3%D8%A9-%D8%AA%D9%81%D8%B6%D8%AD-%D8%B4%D8%B1%D9%83%D8%A7%D8%AA-%D8%A3%D8%AF%D9%88%D9%8A%D8%A9-%D8%A5%D9%86%D9%82%D8%A7%D8%B5-%D8%A7%D9%84%D9%88%D8%B2%D9%86-%D8%A7%D9%84%D8%AA%D8%AE%D8%B3%D9%8A%D8%B3/

Dmca

LEAVE A REPLY

Please enter your comment!
Please enter your name here